- Home
- Equities - Stocks - Shares
- Company Press Releases
- Amplitude Surgical Announces Its 2022-23 Financial Calendar
Amplitude Surgical Announces Its 2022-23 Financial Calendar
24 Nov 2022 18:00 CET
Issuer
AMPLITUDE SURGICAL
Regulatory News:
Amplitude Surgical (ISIN : FR0012789667, Mnémo : AMPLI, PEA-PME eligible) (Paris:AMPLI), (“Amplitude” or the “Group”), French leader on the global surgical technology market for lower-limb orthopedics, announces its 2022-23 financial calendar.
Events |
Dates * |
2022-23 Q1 Sales |
Thursday, November 24, 2022 |
2022-23 H1 Sales |
Thursday, February 23, 2023 |
2022-23 H1 Results |
Wednesday, March 22, 2023 |
2022-23 Q3 Sales |
Thursday, April 20, 2023 |
2022-23 Full-Year Sales |
Thursday, July 20, 2023 |
2022-23 Full-Year Results |
Wednesday, October 18, 2023 |
2023-24 Q1 Sales |
Thursday, November 23, 2023 |
* Subject to modification. Press releases are published after market closes.
Next press release:
H1 2022-23 sales, on Thursday February 23, 2023, after market.
About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents distributing its products in more than 30 countries. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. At June 30, 2022, Amplitude Surgical had a workforce of 460 employees and recorded sales of nearly 104.8 million euros (including foot and ankle activity and before application of IFRS 5).
View source version on businesswire.com: https://www.businesswire.com/news/home/20221124005213/en/
Amplitude Surgical
Dimitri Borchtch
CFO
finances@amplitude-surgical.com
+33 (0)4 75 41 87 41
NewCap
Investor Relations
Thomas Grojean
amplitude@newcap.eu
+33 (0)1 44 71 94 94
NewCap
Media Relations
Nicolas Merigeau
amplitude@newcap.eu
+33 (0)1 44 71 94 98
Source
AMPLITUDE
Provider
BusinessWire
Company Name
AMPLITUDE SURGICAL
ISIN
FR0012789667
Symbol
AMPLI
Market
Euronext